Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease

NCT03251118 is registered in ClinicalTrials.gov with Target PharmaSolutions, Inc. as lead sponsor.

NCT NCT03251118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03251118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Lead sponsor
Target PharmaSolutions, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
July 24, 2017
Completion date
March 31, 2027
Enrollment
15,000 (estimated)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, indeterminate colitis, inflammatory bowel diseases, ulcerative colitis